Total Clarity Wealth Management’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
OAG
PA
BBA
DM
DCM
CAM
Total Clarity Wealth Management's PRAX Position: Q1 2026 in Review
Total Clarity Wealth Management sold out of Praxis Precision Medicines (PRAX) in Q1 2026, closing a stake of 1,820 shares — an estimated $536K sold.
Total Clarity Wealth Management first reported a position in PRAX in Q4 2025 and held it in 1 quarter. The position peaked at $536K in Q4 2025. 291 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.
- Total Clarity Wealth Management reported no remaining Praxis Precision Medicines position as of Q1 2026 after selling out during the quarter.
- Total Clarity Wealth Management sold 1,820 Praxis Precision Medicines shares in Q1 2026, an estimated $536K.
- Total Clarity Wealth Management first reported a position in Praxis Precision Medicines in Q4 2025 and held it in 1 quarter.
- Total Clarity Wealth Management's Praxis Precision Medicines position peaked at $536K in Q4 2025.
- 291 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.
Based on Total Clarity Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.